[
  {
    "ts": null,
    "headline": "UnitedHealth Group: The Risk Means Sell The Bounce",
    "summary": "UnitedHealth Group: The Risk Means Sell The Bounce",
    "url": "https://finnhub.io/api/news?id=aae76d1333487ead4e6a309f59422f23d215b7f977177d64e1df35084eca7e0e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755809076,
      "headline": "UnitedHealth Group: The Risk Means Sell The Bounce",
      "id": 136473066,
      "image": "",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=aae76d1333487ead4e6a309f59422f23d215b7f977177d64e1df35084eca7e0e"
    }
  },
  {
    "ts": null,
    "headline": "Worried About a Market Crash? Here Are 3 Stocks That ‘Big Short’ Star Michael Burry Loves Here.",
    "summary": "Here are three top stocks that the ‘Big Short’ star Michael Burry owns in Q2 of 2025. Are UNH, REGN, and LULU undervalued right now?",
    "url": "https://finnhub.io/api/news?id=bbe82d96c50052a70181dacd1178c130877136f0e28303e239dd1f04677818d5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755808447,
      "headline": "Worried About a Market Crash? Here Are 3 Stocks That ‘Big Short’ Star Michael Burry Loves Here.",
      "id": 136476689,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Here are three top stocks that the ‘Big Short’ star Michael Burry owns in Q2 of 2025. Are UNH, REGN, and LULU undervalued right now?",
      "url": "https://finnhub.io/api/news?id=bbe82d96c50052a70181dacd1178c130877136f0e28303e239dd1f04677818d5"
    }
  },
  {
    "ts": null,
    "headline": "George Soros Is Betting Big on Beaten-Down UnitedHealth Stock. Should You?",
    "summary": "American investor George Soros is investing in health insurance stock UnitedHealth leading to a spike.",
    "url": "https://finnhub.io/api/news?id=e81994535c974318b89a05f46f80707bb8f91c6322a6ce722bfe228be6dfb8ff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755803674,
      "headline": "George Soros Is Betting Big on Beaten-Down UnitedHealth Stock. Should You?",
      "id": 136476690,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "American investor George Soros is investing in health insurance stock UnitedHealth leading to a spike.",
      "url": "https://finnhub.io/api/news?id=e81994535c974318b89a05f46f80707bb8f91c6322a6ce722bfe228be6dfb8ff"
    }
  },
  {
    "ts": null,
    "headline": "Elevance Health: Piggy Bank Or Headache?",
    "summary": "Elevance Health: Piggy Bank Or Headache?",
    "url": "https://finnhub.io/api/news?id=a2635aa72627e81346716898f8bf8e172798bc7332a40f83c1e7e413ca4f2817",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755798385,
      "headline": "Elevance Health: Piggy Bank Or Headache?",
      "id": 136471079,
      "image": "",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=a2635aa72627e81346716898f8bf8e172798bc7332a40f83c1e7e413ca4f2817"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Ticks as Investors Remain Wary -- Health Care Roundup",
    "summary": "Health Care Ticks as Investors Remain Wary -- Health Care Roundup",
    "url": "https://finnhub.io/api/news?id=ce47288d107c09fbc2f12f81498dc923206419a73e32d996c735ef2d299155f5",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755795420,
      "headline": "Health Care Ticks as Investors Remain Wary -- Health Care Roundup",
      "id": 136488802,
      "image": "",
      "related": "UNH",
      "source": "MarketWatch",
      "summary": "Health Care Ticks as Investors Remain Wary -- Health Care Roundup",
      "url": "https://finnhub.io/api/news?id=ce47288d107c09fbc2f12f81498dc923206419a73e32d996c735ef2d299155f5"
    }
  },
  {
    "ts": null,
    "headline": "UNH or ELV: Which Healthcare Titan Will Regain Investor Trust First?",
    "summary": "UnitedHealth and Elevance battle rising costs, but scale, Optum, and Buffett's backing give UNH the edge in restoring investor trust.",
    "url": "https://finnhub.io/api/news?id=493705c167d7954eda24e465eaf16eb5e423df66d8cda8529a4b9e2694b13a22",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755793080,
      "headline": "UNH or ELV: Which Healthcare Titan Will Regain Investor Trust First?",
      "id": 136471518,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "UnitedHealth and Elevance battle rising costs, but scale, Optum, and Buffett's backing give UNH the edge in restoring investor trust.",
      "url": "https://finnhub.io/api/news?id=493705c167d7954eda24e465eaf16eb5e423df66d8cda8529a4b9e2694b13a22"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Needs Insurers to Cover New HIV Prevention Shot. CVS Isn’t Paying.",
    "summary": "The injection, called Yeztugo, is highly effective, but its list price is $28, 218 a year in the U.S.",
    "url": "https://finnhub.io/api/news?id=be6a70a6aff1c7fca4c0c3fb825b8b94f57db0bf9674ca31f395fafb6eb7f470",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755792900,
      "headline": "Gilead Needs Insurers to Cover New HIV Prevention Shot. CVS Isn’t Paying.",
      "id": 136471519,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "The injection, called Yeztugo, is highly effective, but its list price is $28, 218 a year in the U.S.",
      "url": "https://finnhub.io/api/news?id=be6a70a6aff1c7fca4c0c3fb825b8b94f57db0bf9674ca31f395fafb6eb7f470"
    }
  },
  {
    "ts": null,
    "headline": "Ontic raises $230 million led by KKR as corporate spending on security surges",
    "summary": "(Reuters) -Corporate security software firm Ontic has raised $230 million in a funding round led by alternate investment juggernaut KKR, it said on Friday, as it seeks to expand globally and into the government sector.  Ontic's platform helps corporate security teams respond to physical threats to staff and facilities.  The Series C funding comes at a time when corporate security spending has risen following the fatal shooting of a UnitedHealth Group executive last year, as more companies see heightened threats to their top brass.",
    "url": "https://finnhub.io/api/news?id=b89edb695d2db83beb7782ba941dfa526c74eb2cf35714be018b8da1dcb1136f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755791046,
      "headline": "Ontic raises $230 million led by KKR as corporate spending on security surges",
      "id": 136467650,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "(Reuters) -Corporate security software firm Ontic has raised $230 million in a funding round led by alternate investment juggernaut KKR, it said on Friday, as it seeks to expand globally and into the government sector.  Ontic's platform helps corporate security teams respond to physical threats to staff and facilities.  The Series C funding comes at a time when corporate security spending has risen following the fatal shooting of a UnitedHealth Group executive last year, as more companies see heightened threats to their top brass.",
      "url": "https://finnhub.io/api/news?id=b89edb695d2db83beb7782ba941dfa526c74eb2cf35714be018b8da1dcb1136f"
    }
  },
  {
    "ts": null,
    "headline": "Is This the Right Time to Consider Healthcare ETFs?",
    "summary": "XLV lags SPY by double digits over the past year, but Buffett's UNH bet, hedge fund buys and AI optimism hint at a healthcare revival.",
    "url": "https://finnhub.io/api/news?id=6ea5184fc7534f60aa5f43a659c2d6e7645682cc34059adfdfdb6ffb1ee2f1ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755788400,
      "headline": "Is This the Right Time to Consider Healthcare ETFs?",
      "id": 136467651,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "XLV lags SPY by double digits over the past year, but Buffett's UNH bet, hedge fund buys and AI optimism hint at a healthcare revival.",
      "url": "https://finnhub.io/api/news?id=6ea5184fc7534f60aa5f43a659c2d6e7645682cc34059adfdfdb6ffb1ee2f1ee"
    }
  },
  {
    "ts": null,
    "headline": "As Buffett as it Gets: 7 Reasons Why Berkshire Hathaway Just Bought This Monster Health Insurance Stock",
    "summary": "Berkshire's latest 13F is out, and one savvy new position sticks out among the pack.",
    "url": "https://finnhub.io/api/news?id=7990eda757bf923b306b629a6dba690b6611b2cf5a24d5bcaa7137eada772801",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755785700,
      "headline": "As Buffett as it Gets: 7 Reasons Why Berkshire Hathaway Just Bought This Monster Health Insurance Stock",
      "id": 136467652,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Berkshire's latest 13F is out, and one savvy new position sticks out among the pack.",
      "url": "https://finnhub.io/api/news?id=7990eda757bf923b306b629a6dba690b6611b2cf5a24d5bcaa7137eada772801"
    }
  },
  {
    "ts": null,
    "headline": "Value Outshines Growth: 5 ETF Winners Over the Past Week",
    "summary": "Value ETFs witness a surge as tech falters, with SPVU, RPV, RZV, RFV and GVLU gaining on rate cut bets and rotation into defensive sectors.",
    "url": "https://finnhub.io/api/news?id=4a171a6b5639c26e8d5ff8973eba566e4685a351c9ace5b63288a92acda6af29",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755784800,
      "headline": "Value Outshines Growth: 5 ETF Winners Over the Past Week",
      "id": 136467653,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Value ETFs witness a surge as tech falters, with SPVU, RPV, RZV, RFV and GVLU gaining on rate cut bets and rotation into defensive sectors.",
      "url": "https://finnhub.io/api/news?id=4a171a6b5639c26e8d5ff8973eba566e4685a351c9ace5b63288a92acda6af29"
    }
  },
  {
    "ts": null,
    "headline": "Update: Market Chatter: CVS Health Won't Cover Gilead's New HIV Prevention Drug Yet",
    "summary": "(Update to add Gilead's comment in the fourth paragraph) CVS Health (CVS) has decided not to incl",
    "url": "https://finnhub.io/api/news?id=4bc881779c3de61e9ec0223c99188902d719f2054e596f1329f340b0e310734c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755782468,
      "headline": "Update: Market Chatter: CVS Health Won't Cover Gilead's New HIV Prevention Drug Yet",
      "id": 136467654,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "(Update to add Gilead's comment in the fourth paragraph) CVS Health (CVS) has decided not to incl",
      "url": "https://finnhub.io/api/news?id=4bc881779c3de61e9ec0223c99188902d719f2054e596f1329f340b0e310734c"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=c3340c0fcd2cb2419389b06edc96d67dca813e08ba1e369adae4236c055d827d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755781202,
      "headline": "UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know",
      "id": 136467655,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=c3340c0fcd2cb2419389b06edc96d67dca813e08ba1e369adae4236c055d827d"
    }
  },
  {
    "ts": null,
    "headline": "Warren Buffett's Modest Stake a Boost for UnitedHealth, But Work Left to be Done",
    "summary": "Berkshire Hathaway's (BRK.A, BRK.B) recent disclosure that it bought $1.6 billion of UnitedHealth Gr",
    "url": "https://finnhub.io/api/news?id=0dde0e0c14733dd4fe1015d8866701fc4f558f2ddbaeaef8d431d5ed86aeaeec",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755778152,
      "headline": "Warren Buffett's Modest Stake a Boost for UnitedHealth, But Work Left to be Done",
      "id": 136467453,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Berkshire Hathaway's (BRK.A, BRK.B) recent disclosure that it bought $1.6 billion of UnitedHealth Gr",
      "url": "https://finnhub.io/api/news?id=0dde0e0c14733dd4fe1015d8866701fc4f558f2ddbaeaef8d431d5ed86aeaeec"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Stock Runs Hot Once Again, Hitting A New Buy Point",
    "summary": "CVS Health stock offers an above-average dividend yield for investors seeking income and it's run up to a new buy point.",
    "url": "https://finnhub.io/api/news?id=8eac78ca19ca1997c28d5b3bf4fed8a22e7e5d7268361fc04bf3412e848965f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755777609,
      "headline": "CVS Health Stock Runs Hot Once Again, Hitting A New Buy Point",
      "id": 136467657,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "CVS Health stock offers an above-average dividend yield for investors seeking income and it's run up to a new buy point.",
      "url": "https://finnhub.io/api/news?id=8eac78ca19ca1997c28d5b3bf4fed8a22e7e5d7268361fc04bf3412e848965f0"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare Stocks Are the Cheapest They‘ve Been in 30 Years—and a Turnaround May Have Already Started",
    "summary": "Healthcare stocks have been in a funk.  For investors worried about elevated market valuations, they may be just what the doctor ordered.  The healthcare sector is enduring one of its worst patches on record, thanks to a slew of problems that include managed care costs and stiffening competition among blockbuster weight-loss drugs.",
    "url": "https://finnhub.io/api/news?id=ae75e90fa583f89216271194be2a6861dbdd05aa2967671d7af65fa90ea5029d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755776340,
      "headline": "Healthcare Stocks Are the Cheapest They‘ve Been in 30 Years—and a Turnaround May Have Already Started",
      "id": 136467564,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Healthcare stocks have been in a funk.  For investors worried about elevated market valuations, they may be just what the doctor ordered.  The healthcare sector is enduring one of its worst patches on record, thanks to a slew of problems that include managed care costs and stiffening competition among blockbuster weight-loss drugs.",
      "url": "https://finnhub.io/api/news?id=ae75e90fa583f89216271194be2a6861dbdd05aa2967671d7af65fa90ea5029d"
    }
  },
  {
    "ts": null,
    "headline": "Long Call Butterfly Trade Ideas for August 21st",
    "summary": "The screener shows some interesting long call butterfly trades on popular stocks such NVDA, AAPL, MSFT, TSLA and UNH.",
    "url": "https://finnhub.io/api/news?id=0b302f14c19efa26e83fb125ee455a123589c9d6171c2a789bd45761fc4d8b39",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755774002,
      "headline": "Long Call Butterfly Trade Ideas for August 21st",
      "id": 136467440,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "The screener shows some interesting long call butterfly trades on popular stocks such NVDA, AAPL, MSFT, TSLA and UNH.",
      "url": "https://finnhub.io/api/news?id=0b302f14c19efa26e83fb125ee455a123589c9d6171c2a789bd45761fc4d8b39"
    }
  },
  {
    "ts": null,
    "headline": "Market Chatter: CVS Health Won't Cover Gilead's New HIV Prevention Drug Yet",
    "summary": "CVS Health (CVS) has decided not to include Gilead Sciences' (GILD) new HIV prevention drug, Yeztugo",
    "url": "https://finnhub.io/api/news?id=e63848e550ef812bca0552da187fba5b54b7291fa7137f25c22ab856146c21e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755772465,
      "headline": "Market Chatter: CVS Health Won't Cover Gilead's New HIV Prevention Drug Yet",
      "id": 136467660,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "CVS Health (CVS) has decided not to include Gilead Sciences' (GILD) new HIV prevention drug, Yeztugo",
      "url": "https://finnhub.io/api/news?id=e63848e550ef812bca0552da187fba5b54b7291fa7137f25c22ab856146c21e4"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Healthcare Fund Q2 2025 Commentary",
    "summary": "The Hartford Healthcare Fund (I Share) outperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=f8b7703fb46da00d8ea965f9f056688fcf2528cb789b78bb6f1c7c7ea46efb79",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755771900,
      "headline": "Hartford Healthcare Fund Q2 2025 Commentary",
      "id": 136458913,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/685006799/image_685006799.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "The Hartford Healthcare Fund (I Share) outperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=f8b7703fb46da00d8ea965f9f056688fcf2528cb789b78bb6f1c7c7ea46efb79"
    }
  },
  {
    "ts": null,
    "headline": "White House data sharing plan boasts big ambitions, but has scant details",
    "summary": "Improving health data exchange is a worthy goal, but the initiative so far includes few details on how it will work — and has plenty of barriers to overcome, experts say.",
    "url": "https://finnhub.io/api/news?id=0aacf8f386e1dcaef92c4cdc9de25d2f9aacf304401f1c560c37103b02d1f824",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755771067,
      "headline": "White House data sharing plan boasts big ambitions, but has scant details",
      "id": 136467661,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Improving health data exchange is a worthy goal, but the initiative so far includes few details on how it will work — and has plenty of barriers to overcome, experts say.",
      "url": "https://finnhub.io/api/news?id=0aacf8f386e1dcaef92c4cdc9de25d2f9aacf304401f1c560c37103b02d1f824"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Capital Appreciation Fund Q2 2025 Commentary",
    "summary": "Hartford Capital Appreciation Fund (I Share) underperformed the Russell 3000 Index during the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=9adba1f03da819bb814fa2a1536c39a379db9f75183d0032f41492f3ccb063ff",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755771000,
      "headline": "Hartford Capital Appreciation Fund Q2 2025 Commentary",
      "id": 136457522,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2202413157/image_2202413157.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "Hartford Capital Appreciation Fund (I Share) underperformed the Russell 3000 Index during the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=9adba1f03da819bb814fa2a1536c39a379db9f75183d0032f41492f3ccb063ff"
    }
  },
  {
    "ts": null,
    "headline": "Time to Buy UnitedHealth-Heavy ETFs?",
    "summary": "Berkshire's $1.57B stake in UnitedHealth lifted shares by 12%, sparking interest in UNH-heavy healthcare ETFs like IHF, TMED, XLV and MEDI.",
    "url": "https://finnhub.io/api/news?id=b5ebd974ecb805a42b4ef605aee1545002f0c9b8aea51361999e2da47c7c166d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755770400,
      "headline": "Time to Buy UnitedHealth-Heavy ETFs?",
      "id": 136467662,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Berkshire's $1.57B stake in UnitedHealth lifted shares by 12%, sparking interest in UNH-heavy healthcare ETFs like IHF, TMED, XLV and MEDI.",
      "url": "https://finnhub.io/api/news?id=b5ebd974ecb805a42b4ef605aee1545002f0c9b8aea51361999e2da47c7c166d"
    }
  },
  {
    "ts": null,
    "headline": "Hartford Dividend And Growth Fund Q2 2025 Commentary",
    "summary": "Hartford Dividend and Growth Fund (I Share) underperformed the S&P 500 Index for the quarter. Read more here.",
    "url": "https://finnhub.io/api/news?id=d9c287141d746b4095a605da55dbd8ef1e485ad1716564cc1d5ef0af54b1bf27",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755770400,
      "headline": "Hartford Dividend And Growth Fund Q2 2025 Commentary",
      "id": 136456911,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2182036952/image_2182036952.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "Hartford Dividend and Growth Fund (I Share) underperformed the S&P 500 Index for the quarter. Read more here.",
      "url": "https://finnhub.io/api/news?id=d9c287141d746b4095a605da55dbd8ef1e485ad1716564cc1d5ef0af54b1bf27"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth forms new ‘public responsibility’ board committee",
    "summary": "The committee will oversee areas where UnitedHealth has struggled or faced public scrutiny: underwriting and forecasting, regulatory relationships, reputational matters, and M&A.",
    "url": "https://finnhub.io/api/news?id=7bda8ae9fa8879b2ea53c05be902e1ebb359685526cf9dcde8de360f537ed667",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755767001,
      "headline": "UnitedHealth forms new ‘public responsibility’ board committee",
      "id": 136467663,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "The committee will oversee areas where UnitedHealth has struggled or faced public scrutiny: underwriting and forecasting, regulatory relationships, reputational matters, and M&A.",
      "url": "https://finnhub.io/api/news?id=7bda8ae9fa8879b2ea53c05be902e1ebb359685526cf9dcde8de360f537ed667"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth: One Of The Best Risk-To-Reward Ratio On The Market",
    "summary": "UnitedHealth: One Of The Best Risk-To-Reward Ratio On The Market",
    "url": "https://finnhub.io/api/news?id=381086d5d749bcfbe43b2765d1889bbafc56888cdb5a162a3acde7fd9930d90c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755766800,
      "headline": "UnitedHealth: One Of The Best Risk-To-Reward Ratio On The Market",
      "id": 136453242,
      "image": "",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=381086d5d749bcfbe43b2765d1889bbafc56888cdb5a162a3acde7fd9930d90c"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth: With Buffett Or Not, The Rally Is On",
    "summary": "UnitedHealthâs rally is fueled by smart repricing, margin focus, and strong 2026 growth potentialâbeyond just Buffett's stake. Find out why UNH stock is a buy.",
    "url": "https://finnhub.io/api/news?id=8d3c45f390b43b488e74c0e2d9bd390856b4f1b03dbd36b1011fd67f68fab70c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755761510,
      "headline": "UnitedHealth: With Buffett Or Not, The Rally Is On",
      "id": 136452637,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1308861166/image_1308861166.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "UnitedHealthâs rally is fueled by smart repricing, margin focus, and strong 2026 growth potentialâbeyond just Buffett's stake. Find out why UNH stock is a buy.",
      "url": "https://finnhub.io/api/news?id=8d3c45f390b43b488e74c0e2d9bd390856b4f1b03dbd36b1011fd67f68fab70c"
    }
  },
  {
    "ts": null,
    "headline": "UNHG: Leveraging The UnitedHealth Rebound",
    "summary": "Leverage Shares 2X Long UNH Daily ETF offers leveraged exposure to UnitedHealth's stock via derivative positions with mild basis risk. See why UNHG is a Buy.",
    "url": "https://finnhub.io/api/news?id=40608c0ec0a30bee13ea315739f10cbfc5c169e0a686a8bb6f01a182a6d7f8c6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755744458,
      "headline": "UNHG: Leveraging The UnitedHealth Rebound",
      "id": 136450368,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2159946636/image_2159946636.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "Leverage Shares 2X Long UNH Daily ETF offers leveraged exposure to UnitedHealth's stock via derivative positions with mild basis risk. See why UNHG is a Buy.",
      "url": "https://finnhub.io/api/news?id=40608c0ec0a30bee13ea315739f10cbfc5c169e0a686a8bb6f01a182a6d7f8c6"
    }
  }
]